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Objectives: to determine the clinical outcome of subintimal angioplasty (SA) and to assess impact on surgical workload.
Design: retrospective review of a single radiologist's case series.
Materials: one hundred and twenty two patients with critical limb ischaemia and 26 with claudication.
Methods: one hundred and fifty eight limbs treated by SA. Main outcome measures: technical success and complications;
cumulative patency, limb salvage and survival; affect of SA on vascular workload.
Results: the technical success rate was 85%. There were 26 procedural complications (16%) but no patient required
emergency surgery; 30-day mortality was 3%. Primary and secondary 12-month patency rates were 27 and 33%. Limb
salvage rate was 88% at 12 months. SA initially reduced the number of patients needing arterial surgery, although this then
increased due to late failure of SA and an increase in de novo bypass.
Conclusions: SA carries a low risk of major complications and high immediate technical success. Poor long-term patency
suggests that SA is not as durable as bypass surgery. However, failed SA did not compromise subsequent surgery, which
only became necessary in a proportion of patients. Our data suggests that there is little to be lost by using SA as first-line
treatment for patients with limb-threatening ischaemia who are poor operative risks or who have no autologous vein
available.
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The role of percutaneous transluminal angioplasty
(PTA) for intermittent claudication remains contro-
versial despite 35 years' clinical experience. A recent
Cochrane review concluded that angioplasty confers
no clinical benefit for mild to moderate claudication.1
This summarised results from two randomised-
controlled trials comparing angioplasty to exercise
training.2,3 However, angioplasty continues to be
used in an ad hoc way, in spite of increasing evidence
suggesting that claudicants are best treated conserva-
tively with anti-platelet therapy, cardiovascular risk
reduction and exercise training.4
Critical limb ischaemia (CLI) has an annual inci-
dence of 400 per million population in the U.K.5
By definition, treatment is needed for limb salvage.
Frequently, patients present with diffuse femoro-
popliteal or infra-popliteal disease: the recent Trans-
Atlantic Inter-Society Consensus document (TASC)
concludes that these are best treated by surgery,Please address all correspondence to: P. V. Tisi, Consultant
Vascular Surgeon, Bedford Hospital, Kempston Road, Bedford,
Bedfordshire MK42 9DJ, U.K.
1078±5884/02/050417 06 $35.00/0 # 2002 Elsevier Science Ltd. Alwhere possible.6 However, surgery represents a
physiological challenge to this, often frail group of
patients. Subintimal angioplasty (SA), pioneered by
the Leicester group in the U.K.7 can treat more com-
plex disease patterns than conventional PTA, broad-
ening the indications for endovascular treatment.
Computer modelling has shown that angioplasty for
ischaemic rest pain can increase quality-adjusted life
expectancy and decrease lifetime treatment cost com-
pared to surgery.8
However, several retrospective studies have shown
that despite increased use of PTA, the rate of surgery
continues to rise while the major amputation rate is
unchanged.9,10 No series has included the effect of
SA on clinical practice. The aim of this study was
therefore to determine the clinical outcome of SA in
our unit and to determine the impact on surgical
workload.
Method
SA was introduced into clinical practice in this hos-
pital in 1997. Diagnostic angiograms were reviewed atl rights reserved.
Table 1. Demographic data.
Smoking
Current 37 (25%)
Ex-smoker4 1 year 69 (47%)
Non-smoker 34 (23%)
Unknown 8 (5%)
Diabetes
Insulin-dependent 16 (11%)
Non-insulin dependent 27 (18%)
Not diabetic 97 (66%)
Unknown 8 (5%)
Hypertension
Untreated4 150/90 18 (12%)
Treated 61 (41%)
Normal blood pressure 60 (41%)
Unknown 9 (6%)
Hyperlipidaemia
Untreated 8 (5%)
Treated 13 (9%)
Normal lipids 42 (28%)
Not measured 75 (51%)
Unknown 10 (7%)
Ischaemic heart disease
None 84 (57%)
Unknown 8 (5%)
Ischaemic heart disease 56 (38%)
(Angina) (33)
(LVF) (1)
(Myocardial infarction) (22)
(Coronary artery bypass) (3)
Cerebrovascular disease
None 108 (73%)
Unknown 11 (7%)
Cerebrovascular disease 29 (20%)
(Stroke) (19)
(TIA) (9)
(Carotid endarterectomy) (1)
Figures shown are number (%) of patients (LVF, left ventricular
failure; TIA, transient ischaemic attack).
418 P. V. Tisi et al.the multidisciplinary vascular meeting. All cases
potentially treatable by SA underwent this procedure,
including those suitable for bypass surgery, but
excluding lesions treatable by PTA. Data was
extracted from a consecutive series of 166 limbs
(156 patients) treated by a single interventional radi-
ologist, including the learning curve. Eight patients
treated with iliac SA were excluded from further
analysis. The procedure was carried out using a stan-
dardised technique.7 Indications for treatment were
CLI or lifestyle-limiting claudication. Hospital notes
were reviewed retrospectively and patients were
invited to re-attend for outpatient follow-up. Grading
of limb ischaemia and angioplasty patency rates were
reported according to the revised SVS/ISCVS
criteria11 and the TASC document.6 For purposes of
this study, claudication grades 1 to 3 were defined
according to patient-reported walking distances of
4250 m, 50±200 m and 550 m respectively. Short-
term patency required an angiographic improvement
(530% residual stenosis), an increase in ankle-
brachial pressure index (ABPI) by 40.1 and an
improvement in clinical category.11 For tissue loss,
this required complete ulcer healing. Long-term
patency was defined as maintenance of both the
improvement in clinical category and the increased
ABPI ( 0.1 below maximum post-angioplasty
value). Duplex ultrasound was used to confirm
patency if there was a reduction in ABPI. However,
any deterioration in clinical status was considered as a
treatment failure. All results were reported as inten-
tion to treat. Data was analysed using the life-table
method and patency curves compared with the
Mantel±Haenszel test.
Corresponding data on surgical and radiological
workload for CLI between 1996 and 1999 was
extracted from a prospectively gathered departmental
database.
Results
Subintimal angioplasty
One hundred and forty eight patients (55% men,
45% women) underwent SA between 1997 and 1999.
The median (interquartile range (IQR)) age was 77.5
(70±82) years. Demographic data are shown in Table 1.
Sixty-four patients (43%) were taking low-dose aspirin
while a further 13 (9%) were intolerant of aspirin.
All patients were prescribed aspirin after the pro-
cedure unless intolerant. Fifty-four patients (36%)
had previously undergone intervention for lowerEur J Vasc Endovasc Surg Vol 24, November 2002limb ischaemia, including ipsilateral angioplasty in
26 cases and surgery in three cases.
There were 29 claudicant limbs in 26 patients
(Rutherford grades 1 to 3) with a median (IQR)
reported walking distance of 51 m (23±91). There
were 129 limbs with CLI in 122 patients. One hundred
and one limbs had tissue loss (Rutherford grade 5)
with peripheral gangrene in six cases and ischaemic
ulceration in the remainder. Twenty eight limbs had
rest pain alone (Rutherford grade 4), while a further
51 had rest pain and tissue loss with a median (IQR)
duration of 7 weeks (3 weeks to 4 months). The
median (IQR) ABPI was 0.55 (0.40±0.66) with an abso-
lute ankle systolic pressure of 80 mmHg (61±110).
Diagnostic angiography revealed 135 arterial occlu-
sions and 12 stenoses, with no information available
on 11 limbs. The median occlusion length was 10 cm
(IQR 5±16, range 3±60). This was distributed in the
femoro-popliteal segment in 122 (77%) and crural ves-
sels in 36 (23%). According to TASC morphology12
lesions were graded as Type A in one limb, B in
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Subintimal Angioplasty for Lower Limb Ischaemia 41936 limbs, C in 74 limbs and D in 41 limbs. There were
three run-off vessels in 24 limbs (15%), two vessels in
49 limbs (31%), one vessel in 48 limbs (30%) and no
run-off in 23 limbs (15%); there was missing run-off
data in 14 limbs.
The site of entry into the subintimal plane and re-
entry back into the vessel lumen is shown in Table 2.
The technical success rate of the procedure was 85%.
Of 23 technical failures, most were due to failed cre-
ation of a subintimal plane (n 10) or failed re-entry
back into the lumen (n 7). The subintimal channel
collapsed in four patients and immediately throm-
bosed in one patient. There was significant vessel
perforation in three patients, leading to abandonment
of the procedure. Nine technical failures required no
further intervention while three proceeded to major
amputation. Eleven patients subsequently underwent
successful bypass surgery: one graft later occluded,
requiring a below knee amputation at two months.
The complication rate from the procedure was 16%
(26 limbs): haematoma (n 12), vessel perforation
(n 8), thrombosis (n 3), distal embolus (n 1), ves-
sel spasm (n 1) and myocardial infarction (n 1). No
patient required emergency surgery for a procedure-
related complication, and seven patients underwent
successful immediate endovascular treatment.
Early results
The median (IQR) increase in ABPI following the pro-
cedure was 0.18 (0±0.40). At 30 days, 21 limbs were
normalised (asymptomatic with an ABPI4 1.0) and
43 limbs improved in both ABPI and clinical category.
Twenty-six limbs showed either an improvement in
ABPI or clinical category, and are therefore not strictly
`` patent'' according to the SVS/ISCVS criteria.11 There
was no change of clinical category in 47 limbs and a
deterioration of ABPI and/or clinical category in 13
limbs. Overall, 30-day primary and secondary patency
rates by strict criteria were 45 and 46% respectively.Table 2. Site of entry into subintimal plane and
re-entry back into vessel lumen (SFA, superficial
femoral artery).
Subintimal
plane
Re-entry to
lumen
Number of
cases (%)
SFA SFA 18 (11)
SFA Popliteal 76 (48)
SFA Crural 13 (8)
Popliteal Popliteal 7 (4)
Popliteal Crural 26 (16)
Crural Crural 18 (11)Thirty-day mortality was 3% (four patients), all in
technical successes. The cause of death was myocar-
dial infarction (n 1), cardiac failure (n 1) and of
uncertain aetiology (n 2).
Follow-up
Patients were assessed by clinical and haemodynamic
criteria. Those with an improved clinical category but
a decrease4 0.1 in post-angioplasty ABPI were fur-
ther investigated with Duplex ultrasound (n 26) or
angiography (n 3). Cumulative primary and second-
ary patency rates according to the life-table method
are shown in Fig. 1. Six patients were excluded from
the life-tables because of missing data. There was an
obvious attrition rate from 1 month onwards, with
primary and secondary patency rates of 27 and 33%
at 12 months. Patency rates in claudicants and those
with CLI were not statistically different: primary
patency 48% vs 24% at 12 months (Mantel±Haenszel,
chi-squared 3.60, p5 0.10) (Fig. 2); secondary
patency 58% vs 28% at 12 months (chi-squared 3.07,
p5 0.10). There was no statistical difference in pri-
mary patency at 12 months in limbs with crural vessel
disease (16%) vs femoro-popliteal segment disease
(30%) (chi-squared 1.74, p4 0.10). Run-off had no
significant effect on patency rates. Primary patency
at 12 months was 32, 21, 28 and 40% with zero, one,
two and three run-off vessels respectively (Mantel±
Haenszel chi-squared 2.91, p4 0.10). Did the
learning curve affect patency rates? The series was
analysed according to `` early'' (1997±1998, 83 cases)0
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Fig. 1. Cumulative primary and secondary patency rates for sub-
intimal angioplasty according to the revised SVS/ISCVS criteria.
Numbers of limbs at risk at the beginning of each time interval are
shown above the x-axis.
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Fig. 2. Cumulative primary patency rates stratified for claudication
and critical limb ischaemia (CLI). Numbers of limbs at risk at the
beginning of each time interval are shown above the x-axis.
0
20
40
60
80
100
0 6 12 18 24
Time (months)
C
um
ul
at
iv
e 
li
m
b 
sa
lv
ag
e 
(%
)
126          103                 86               69           52                                     33                 11 
Fig. 3. Cumulative limb salvage rates for critical limb ischaemia.
Numbers of limbs at risk at the beginning of each time interval are
shown above the x-axis.
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Fig. 4. Workload for critical limb ischaemia between 1996 and 1999
(PTA, percutaneous transluminal angioplasty). Number of patients
undergoing subintimal angioplasty includes claudicants but
excludes iliac cases.
420 P. V. Tisi et al.and `` late'' (1999, 69 cases) sub-groups. Primary
patency at 12 months was 20% in the `` late'' group
and 32% in the `` early'' (i.e. learning curve) group
(Mantel±Haenszel chi-squared 1.58, p4 0.10).
Seventeen patients (11%) underwent further late
radiological intervention following failed SA, while
34 (23%) proceeded to elective surgery.
There were no amputations in the claudicants.
Despite poor patency in those with CLI, the cumula-
tive limb salvage rate was 86 and 84% at one and two
years (Fig. 3). Twelve month limb salvage was similar
in both femoro-popliteal and crural segments (89%
vs 85%) and `` early'' and `` late'' cases respectivelyEur J Vasc Endovasc Surg Vol 24, November 2002(87% vs 89%). Fifteen patients (10%) required a major
amputation during the study period. Seven patients
underwent primary amputation, three in technical
failures and four following reocclusion of a previously
dilated segment. The remaining eight patients under-
went surgical (n 7 femoro-popliteal/distal bypass)
or radiological intervention (repeat SA) before under-
going major amputation at a median 6 months follow-
ing initial SA. Cumulative 2-year survival was 97% in
claudicants and 60% in those with CLI. The single
death in the claudicant group was due to a myocardial
infarction at 30 days.
Clinical workload
Workload patterns for SA, PTA, bypass surgery and
major amputation for chronic lower limb ischaemia
are shown in Figure 4. Introduction of SA led to a
slight decline in numbers of PTA and major amputa-
tions. There was a fall in surgical bypass procedures in
the year after SA was introduced (1998) although in
the following year numbers increased above baseline.
This is a reflection of secondary reconstruction follow-
ing failed SA (n 22, 1999) but also an increase in
de novo bypass i.e. patients who had not undergone
previous SA (n 92, 1999). This represents an increase
in overall workload for chronic lower limb ischaemia,
i.e. 114 cases in 1997, 151 cases in 1998 and 189 cases
in 1999.
Discussion
Subintimal angioplasty attempts to overcome the pro-
blems of PTA by creating a smooth neo-lumen. The
Subintimal Angioplasty for Lower Limb Ischaemia 421technique was initially described by Bolia et al. in
Leicester for femoro-popliteal and crural lesions7 and
has been extended to iliac occlusions.13 SA is undoubt-
edly operator-dependent. Anecdotal reports suggest
that the most frequent technical problem is failure to
re-enter the vessel lumen distal to the disease. Two
cases of spontaneous communication between the
neo-lumen and the true lumen following failed SA
have been described.14
Despite good technical success, the patency rates in
this series are disappointing and are not influenced by
symptoms, level of disease or infrapopliteal run-off,
although a type II error cannot be excluded. However,
patency may be underestimated due to the rigorous
SVS/ISCVS reporting criteria. For example, complete
ulcer healing is required to achieve clinical patency,
which excludes patients who show signs of ulcer heal-
ing. Six patients had a significant improvement in
ABPI following SA, although still had active ulcer-
ation. These were considered as `` occluded'' in the
analyses. As this was a retrospective study, it is diffi-
cult to ascertain whether these ulcers were purely
ischaemic, or whether there was another component,
e.g. venous disease. Nonetheless, patients required
intervention on clinical grounds.
Technical success rates of 76±80% can be achieved
with SA of femoro-popliteal lesions.15,16 Of these tech-
nical successes, up to 84% show clinical improvement
at 6 months.15 The Leicester series of 200 consecutive
femoro-popliteal occlusions quotes haemodynamic
and symptomatic patency of 71 and 73% at 12 months.
Reekers et al. reported similar figures in 40 femoro-
popliteal occlusions treated by SA, with primary
and secondary clinical patency of 59 and 65% at two
years.17 For crural SA, a technical success rate of
86% can be achieved.18 Reported patency rates for
crural lesions are disappointing with haemodynamic
and symptomatic 12-month patency rates of 53 and
56% respectively albeit in a small series of 28 limbs.19
McCarthy et al. recently reported a series of 69 SA
cases treated in two centres.20 For patients with
CLI, SA was used if surgery was not considered feas-
ible. This must necessarily skew the results. Only two
cases underwent crural SA. The reported technical
success rate was 74% with haemodynamic and
symptomatic patency of 51 and 60% at 6 months. It
would be enlightening to re-examine data from these
other studies using the SVS/ISCVS11 or TASC6
criteria.
In our study, patency rates did not improve after
the learning curve. This could reflect confidence in
treating more difficult cases but may be influenced
by the shorter follow-up in this group, i.e. a smaller
sample size.In terms of workload, SA can reduce the need for
early bypass surgery, although later surgery may be
required to deal with late reocclusion of the dilated
segment. The Leicester group have shown that 42.3%
of patients with CLI can be treated with angioplasty
alone, with a further 6.3% treated by a combination of
bypass and angioplasty.21
In attempting to hone our own indications for SA,
we now consider claudication to be a relative contra-
indication. Although our morbidity from intervention
in claudicants was low, there were three technical
failures, of whom two required elective bypass
surgery.
In our experience, SA can be performed with good
initial technical success and a low risk of major com-
plications. It does not prejudice the success of surgery
in the event of a technical failure or a subsequent
occlusion. Despite poor patency, excellent limb sal-
vage rates were achieved in patients with CLI, which
supports the findings of several studies showing limb
salvage despite unreconstructable disease or failed
revascularisation.6 Some patients undoubtedly choose
to persist with stable chronic ischaemic ulcers or rest
pain rather than undergoing amputation.
In conclusion, fit patients with limb-threatening
ischaemia can be offered either surgery or SA, as our
results show that there is `` nothing to lose'' by using
SA as first-line treatment. In the absence of a suitable
venous conduit and in patients unfit for anaesthesia or
with a limited life expectancy, SA may offer the best
chance of avoiding a major amputation. In all cases,
careful clinical judgement is required.
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